Distinguishing fibromyalgia from rheumatoid arthritis and systemic lupus in clinical questionnaires: An analysis of the revised Fibromyalgia Impact Questionnaire (FIQR) and its variant, the Symptom Impact Questionnaire (SIQR), along with pain locations

Arthritis Research and Therapy

Volumn 13, Issue 2, 2011, Pages

  Friend, Ronald ^a,b   Bennett, Robert M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARM PAIN; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; HAND PAIN; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MIDLOWER BACK PAIN; NECK PAIN; OUTER LOWER BACK PAIN; PAIN; PAIN ASSESSMENT; RHEUMATOID ARTHRITIS; SITTING; STRUCTURED QUESTIONNAIRE; SYMPTOM IMPACT QUESTIONNAIRE; SYSTEMIC LUPUS ERYTHEMATOSUS; MUSCULOSKELETAL PAIN; QUESTIONNAIRE;

ARTHRITIS, RHEUMATOID; FIBROMYALGIA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MUSCULOSKELETAL PAIN; QUESTIONNAIRES;

EID: 79953766045     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3311     Document Type: Article

References (18)

1. White KP, Harth M, Speechley M, Ostbye T. Testing an instrument to screen for fibromyalgia syndrome in general population studies: the London Fibromyalgia Epidemiology Study Screening Questionnaire. J Rheumatol 1999, 26:880-884.
2. Häuser W, Akritidou I, Felde E, Klauenberg S, Maier C, Hoffmann A, Köllner V, Hinz A. [Steps towards a symptom-based diagnosis of fibromyalgia syndrome: symptom profiles of patients from different clinical settings] [in German]. Z Rheumatol 2008, 67:511-515. 10.1007/s00393-008-0327-0, 18830659.
3. Perrot S, Bouhassira D, Fermanian J, . Cercle d'Etude de la Douleur en Rhumatologie Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain 2010, 150:250-256. 10.1016/j.pain.2010.03.034, 20488620, Cercle d'Etude de la Douleur en Rhumatologie.
4. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010, 62:600-610. 10.1002/acr.20140, 20461783.
5. Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 2006, 54:169-176. 10.1002/art.21533, 16385512.
6. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis ResTher 2009, 11:R120.
7. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991, 18:728-733.
8. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 1989, New York: Harper and Row, 2.
9. Choy EH, Arnold LM, Clauw DJ, Crofford LJ, Glass JM, Simon LS, Martin SA, Strand CV, Williams DA, Mease PJ. Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 2009, 36:2330-2334. 10.3899/jrheum.090368, 19820222.
10. Watson NF, Buchwald D, Goldberg J, Noonan C, Ellenbogen RG. Neurologic signs and symptoms in fibromyalgia. Arthritis Rheum 2009, 60:2839-2844. 10.1002/art.24772, 2769083, 19714636.
11. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172. 10.1002/art.1780330203, 2306288.
12. Vrijhoef HJ, Diederiks JP, Spreeuwenberg C, van der Linden S. Applying low disease activity criteria using the DAS28 to assess stability in patients with rheumatoid arthritis. Ann Rheum Dis 2003, 62:419-422. 10.1136/ard.62.5.419, 1754526, 12695152.
13. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials: The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993, 36:729-740. 10.1002/art.1780360601, 8507213.
14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
15. Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford) 2010, 49:924-928. 10.1093/rheumatology/kep458, 20100795.
16. Kalichman L, Hernández-Molina G. Hand osteoarthritis: an epidemiological perspective. Semin Arthritis Rheum 2010, 39:465-476. 10.1016/j.semarthrit.2009.03.001, 19482338.
17. Tassiulas IO, Boumpas DT. Clinical features and treatment of systemic lupus erythematosus. Kelley's Textbook of Rheumatology 2009, II:1269. Philadelphia: Saunders/Elsevier, Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS, 8.
18. Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994, 37:1181-1188. 10.1002/art.1780370812, 8053957.